Circle Pharma is an early stage biotechnology company applying proprietary computational design algorithms and innovative chemistry to develop cell permeable macrocycle peptide therapeutics against important clinical targets. It does this through an iterative, rational design process that deploys large virtual libraries of conformationally diverse macrocycle scaffolds selected for inherent permeability.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 09/22/14 | undisclosed | Seed |
Mission Bay Capital Pfizer Strategic Investments Group | undisclosed |
| 04/25/17 | $2,000,000 | Series A Extension |
Elements Partners LifeForce Capital Whitesun Healthcare Ventures WI Harper Group | undisclosed |
| 03/18/20 | $45,000,000 | Series B |
Berkeley Catalyst Fund LifeForce Capital Nextech Invest ShangPharma Investment Group The Column Group  | undisclosed |
| 09/03/24 | $90,000,000 | Series D |
Euclidean Capital Nextech Invest The Column Group | undisclosed |
